COMP <GO>
SSII vs CARL // RSI-14 & 200D SMA MOMENTUM
SS Innovations International Inc. (NASDAQ) VS. Carlsmed Inc. (NASDAQ) • 15-METRIC TALLY: SSII 6
— CARL 3
▲ RSI-14 & 200D SMA MOMENTUM LEADER: CARL
LAST: $2.35 (-1.26%) • MKT CAP: $477.2M
rsi-technicals
37.7
LAST: $14.95 (-5.20%) • MKT CAP: $430.6M
rsi-technicals
59.5
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SSII VS. CARL)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SSII | CARL | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.00% | 75.30% | -29.30 | CARL | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.50% | -35.00% | +16.50 | SSII | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.65% | -6.88% | +2.23 | SSII | /fcf-yield <GO> |
| Operating Margin | -19.30% | -60.00% | +40.70 | SSII | /operating-margins <GO> |
| Net Profit Margin | -28.50% | -58.70% | +30.20 | SSII | /net-margins <GO> |
| Revenue Growth (YoY) | 105.70% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.47 | 7.83 | -0.36 | CARL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | SSII | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 37.7 | 59.5 | -21.80 | CARL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $477.2M | $430.6M | $46.6M | SSII | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SSII REV | CARL REV | SSII GROSS % | CARL GROSS % | SSII FCF | CARL FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $42.5M | $50.5M | 46.0% | 75.3% | -$22.2M | -$29.6M |
| FY 2024 | $20.6M | $27.2M | 40.9% | 73.8% | -$10.2M | -$25.6M |
| FY 2023 | $5.9M | — | — | — | -$15.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SSII // BETA —
CARL // BETA —